Literature DB >> 15197323

Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity?

B Marples1.   

Abstract

Low-dose hyper-radiosensitivity describes a phenomenon by which cells die from excessive sensitivity to small single doses of ionizing radiation below approximately 20-30 cGy. This review describes experimental data that strongly imply that low-dose hyper-radiosensitivity is exclusively associated with the survival response of cells in the G2 phase of the cycle. This G2-centric concept arose when the characteristic cell survival pattern that denotes low-dose hyper-radiosensitivity was not detected in the radiation survival response of cell populations enriched in G1 or S phase cells. In contrast, an extended or exaggerated low-dose hyper-radiosensitivity response was evident from populations selected to contain only G2 phase cells by flow cytometry cell sorting. The historical data that has defined the field of low-dose hyper-radiosensitivity will be considered with respect to the radiation sensitivity of, and cell cycle checkpoints specific to, G2 phase cells. A working model of the putative mechanism of low-dose hyper-radiosensitivity will be presented within this context. The foundation of the model is a rapidly occurring dose-dependent pre-mitotic cell-cycle checkpoint that is specific to cells irradiated in the G2 phase. This early G2 phase checkpoint has been demonstrated to exhibit a dose expression profile that is comparable to the cell-survival pattern that defines low-dose hyper-radiosensitivity and is therefore a likely key regulator of the phenomenon.

Mesh:

Year:  2004        PMID: 15197323     DOI: 10.1023/B:CANC.0000031761.61361.2a

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  16 in total

1.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

2.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

3.  Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.

Authors:  Chaim B Colen; Navid Seraji-Bozorgzad; Brian Marples; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

4.  Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.

Authors:  Peter Jacob; Linda Walsh; Markus Eidemüller
Journal:  Radiat Environ Biophys       Date:  2008-05-15       Impact factor: 1.925

5.  A reaction-diffusion model for radiation-induced bystander effects.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2016-12-29       Impact factor: 2.259

6.  Effects of G2-checkpoint dynamics on low-dose hyper-radiosensitivity.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2018-04-20       Impact factor: 2.259

7.  Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.

Authors:  Jordi Farrés; Juan Martín-Caballero; Carlos Martínez; Juan J Lozano; Laura Llacuna; Coral Ampurdanés; Cristina Ruiz-Herguido; Françoise Dantzer; Valérie Schreiber; Andreas Villunger; Anna Bigas; José Yélamos
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

8.  Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells.

Authors:  Yanxia Zhao; Yingshan Cui; Jun Han; Jinghua Ren; Gang Wu; Jing Cheng
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

9.  The role of nitric oxide radicals in removal of hyper-radiosensitivity by priming irradiation.

Authors:  Nina Jeppesen Edin; Joe Alexander Sandvik; Hilde Synnøve Vollan; Katharina Reger; Agnes Görlach; Erik Olai Pettersen
Journal:  J Radiat Res       Date:  2013-05-17       Impact factor: 2.724

10.  Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine.

Authors:  Arpan V Prabhu; Madison Lee; Edvaldo Galhardo; Madison Newkirk; Analiz Rodriguez; Fen Xia
Journal:  Surg Neurol Int       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.